1-3 of 3
Vassiliki Grigoraki, MD
Close
Sort by
Journal Articles

Mutations in the Exon 12 of the JAK2 Gene Appeared To Be a Rare Event Essentially Clustered in V617F JAK2 Negative PV Patients.

Eirini Kouroupi, MD, Nathalie Parquet, MD, Christine Zoi, MD, Jean-Jacques Kiladjian, MD, Vassiliki Grigoraki, MD, Katerina Zoi, PhD, Linda Scott, PhD, Christine Dosquet, MD, Pierre Fenaux, MD, PhD, Dimitris Loukopoulos, MD, PhD, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD
Journal: Blood
Blood (2007) 110 (11): 2534.
https://doi.org/10.1182/blood.V110.11.2534.2534
Published: 2007
Journal Articles

Prognostic Factors and Outcome of Older Patients with Symptomatic Multiple Myeloma: A Study of the Greek Myeloma Study Group (GMSG).

Athanasios Anagnostopoulos, MD, Dimitra Gika, Argiris Symeonidis, MD, Konstantinos Zervas, MD, Anastasia Pouli, MD, Panagiotis Repoussis, MD, Vassiliki Grigoraki, MD, Nikolaos Anagnostopoulos, MD, Alice G. Maniatis, MD, Meletios Athanasios Dimopoulos, MD
Journal: Blood
Blood (2004) 104 (11): 4847.
https://doi.org/10.1182/blood.V104.11.4847.4847
Published: 2004
Journal Articles

In Multiple Myeloma, Clonal Cells Are Unevenly Distributed among Peripheral Blood B Cell Subpopulations.

Stefanos I. Papadhimitriou, MD, Ioanna Gligori, MSc, Elpiniki Kritikou-Griva, MD, Georgios Gortzolidis, MD, Aggeliki Davea, MD, Georgios S. Paterakis, MD, Eleni Goumakou, MD, Ioanna Savvidou, MD, Vassiliki Grigoraki, MD, Nikolaos I. Anagnostopoulos, MD, Maria Georgiakaki, MD
Journal: Blood
Blood (2004) 104 (11): 1426.
https://doi.org/10.1182/blood.V104.11.1426.1426
Published: 2004